Two Cancer Bills Introduced in the US House of Representatives

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 15 No 7
Volume 15
Issue 7

This new department summarizes current congressional activity relevant to the delivery of cancer care. Two bills recently introduced in the House of Representatives are designed to improve the quality of care for cancer patients on the Medicare program.

This new department summarizes current congressional activity relevant to the delivery of cancer care. Two bills recently introduced in the House of Representatives are designed to improve the quality of care for cancer patients on the Medicare program.

Comprehensive Cancer Care Improvement Act of 2006

Reps. Lois Capps (D-CA) and Tom Davis (R-VA) introduced HR 5465, "to amend title XVIII of the Social Security Act to provide for coverage of comprehensive cancer care planning under the Medicare Program and to improve the care furnished to individuals diagnosed with cancer by establishing a Medicare hospice care demonstration program and grants programs for cancer palliative care and symptom management programs, provider education, and related research."

Of primary interest to oncologists is that HR 5465 would establish a new Medicare service for the development of:

•A treatment plan at the beginning of primary therapy and communication of the plan to the patient

•A cancer care summary and follow-up care plan at the end of primary therapy and communication of it to the patient.

The legislation, supported by the National Coalition for Cancer Survivorship (NCCS), other national patient advocacy groups, and many US cancer centers, also includes provisions to improve symptom management and palliative care for patients undergoing cancer treatment.

Medicare Early Detection of Cancer Promotion Act of 2006

HR 5437, introduced by Rep. Clay Shaw (R-FL), would eliminate coinsurance payments for mammograms and colorectal screenings for Medicare beneficiaries. Currently, Medicare provides coverage for breast, cervical, colon and prostate cancer screening tests, for which the beneficiaries must provide a 20% co-payment.

The bill would amend title XVIII of the Social Security Act to extend for 6 months the eligibility period for the "Welcome to Medicare" physical examination and to eliminate coinsurance for screening mammography and colorectal cancer screening tests in order to promote the early detection of cancer."

The legislation, supported by the American Cancer Society (ACS), also would extend the availability of the "Welcome to Medicare" physical for new beneficiaries from 6 months to 1 year for the next 5 years.

Recent Videos
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Genetic backgrounds and ancestry may hold clues for better understanding pancreatic cancer, which may subsequently mitigate different disparities.
Factors like genetic mutations and smoking may represent red flags in pancreatic cancer detection, said Jose G. Trevino, II, MD, FACS.
Thomas Hope, MD, believes that an NRC initiative to update infiltration guidelines may organically address concerns that H.R. 2541 outlines.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
4 experts are featured in this series.
4 experts are featured in this series.
Thomas Hope, MD, had not observed an adverse effect attributable to an infiltration across more than a decade of administering nuclear agents at UCSF.
Numerous clinical trials vindicating the addition of immunotherapy to first-line chemotherapy in SCLC have emerged over the last several years.
Related Content